These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 36139200)

  • 1. Retrospective Evaluation of a Combination of Carboplatin and Bleomycin for the Treatment of Canine Carcinomas.
    Giuliano A; Almendros A
    Animals (Basel); 2022 Sep; 12(18):. PubMed ID: 36139200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concurrent 5-fluorouracil and carboplatin for the treatment of canine carcinomas.
    Menard K; Flesner BK; Glahn A; Boudreaux B; Bryan JN
    Vet Comp Oncol; 2018 Dec; 16(4):590-595. PubMed ID: 30043425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety evaluation of combination carboplatin and toceranib phosphate (Palladia) in tumour-bearing dogs: A phase I dose finding study.
    Wouda RM; Hocker SE; Higginbotham ML
    Vet Comp Oncol; 2018 Mar; 16(1):E52-E60. PubMed ID: 28799187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retrospective analysis of carboplatin-induced cumulative neutropenia in cancer-bearing dogs.
    Fan V; Delport-Reynolds T; MacDonald-Dickinson V; Matsuyama A
    J Am Vet Med Assoc; 2024 Nov; 262(11):1-7. PubMed ID: 39032511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase II study of carboplatin and continuous infusion bleomycin followed by cisplatin and 5-fluorouracil in recurrent head and neck cancer.
    Huber MH; Lippman SM; Benner SE; Shirinian M; Dimery IW; Earley CL; Winn RJ; Brooks J; Baez L; Hong WK
    Ann Oncol; 1995 Jan; 6(1):83-5. PubMed ID: 7536031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk-adapted chemotherapy of germ cell tumors with carboplatin, etoposide and bleomycin for low-risk and cisplatin, etoposide and ifosfamide for high-risk patients. A single-center study.
    Tscherry G; Jacky E; Jost LM; Stahel RA
    Oncology; 2000 Aug; 59(2):110-7. PubMed ID: 10971168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Canine intranasal tumours treated with alternating carboplatin and doxorubin in conjunction with oral piroxicam: 29 cases.
    Woodruff MJ; Heading KL; Bennett P
    Vet Comp Oncol; 2019 Mar; 17(1):42-48. PubMed ID: 30146732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vinorelbine in combination with carboplatin followed by single-agent consolidation therapy for unresectable localized or metastatic non-small-cell lung carcinomas.
    Alici S; Coskun U; Alkis N; Sevinc A; Dane F; Gumus M; Ozkan M; Kaya AO; Celenkoglu G; Buyukberber S; Altunbas M; Benekli M;
    Asian Pac J Cancer Prev; 2009; 10(6):1051-5. PubMed ID: 20192582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and toxicity of combined oclacitinib and carboplatin or doxorubicin in dogs with solid tumors: a pilot study.
    Barrett LE; Gardner HL; Barber LG; Sadowski A; London CA
    BMC Vet Res; 2019 Aug; 15(1):291. PubMed ID: 31409327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adverse effects of concurrent carboplatin chemotherapy and radiation therapy in dogs.
    Hume KR; Johnson JL; Williams LE
    J Vet Intern Med; 2009; 23(1):24-30. PubMed ID: 19175716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination of Bleomycin and Cytosine Arabinoside Chemotherapy for Relapsed Canine Lymphoma.
    Batschinski K; Dervisis N; Kitchell B; Newman R; Erfourth T
    J Am Anim Hosp Assoc; 2018; 54(3):150-155. PubMed ID: 29558212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carboplatin-induced myelosuppression as related to body weight in dogs.
    Coffee C; Roush JK; Higginbotham ML
    Vet Comp Oncol; 2020 Dec; 18(4):804-810. PubMed ID: 32452107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized trial of cisplatin, etoposide and bleomycin (PEB) versus carboplatin, etoposide and bleomycin (CEB) for patients with 'good-risk' metastatic non-seminomatous germ cell tumors.
    Bokemeyer C; Köhrmann O; Tischler J; Weissbach L; Räth U; Haupt A; Schöffski P; Harstrick A; Schmoll HJ
    Ann Oncol; 1996 Dec; 7(10):1015-21. PubMed ID: 9037359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The evaluation of amifostine for mucosal protection in patients with advanced loco-regional squamous cell carcinomas of the head and neck (SCCHN) treated with concurrent weekly carboplatin, paclitaxel, and daily radiotherapy (RT).
    Suntharalingam M; Jaboin J; Taylor R; Wolf J; Banglore M; Van Echo D; Ord R
    Semin Oncol; 2004 Dec; 31(6 Suppl 18):2-7. PubMed ID: 15726515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brentuximab vedotin combined with ABVD or AVD for patients with newly diagnosed Hodgkin's lymphoma: a phase 1, open-label, dose-escalation study.
    Younes A; Connors JM; Park SI; Fanale M; O'Meara MM; Hunder NN; Huebner D; Ansell SM
    Lancet Oncol; 2013 Dec; 14(13):1348-56. PubMed ID: 24239220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Response and Adverse Event Profile of Bleomycin Chemotherapy for Canine Multicentric Lymphoma.
    Smith AA; Lejeune A; Kow K; Milner RJ; Souza CH
    J Am Anim Hosp Assoc; 2017; 53(2):128-134. PubMed ID: 27841682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase I study of oral ridaforolimus in combination with paclitaxel and carboplatin in patients with solid tumor cancers.
    Chon HS; Kang S; Lee JK; Apte SM; Shahzad MM; Williams-Elson I; Wenham RM
    BMC Cancer; 2017 Jun; 17(1):407. PubMed ID: 28595616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase II trial of bleomycin, ifosfamide, and carboplatin in metastatic cervical cancer.
    Murad AM; Triginelli SA; Ribalta JC
    J Clin Oncol; 1994 Jan; 12(1):55-9. PubMed ID: 7505808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Chronotherapy with high dose carboplatin, 5-fluorouracil and leucovorin in advanced colorectal carcinoma].
    Popov I; Jelić S; Radosavljević D; Nikolić-Tomasević A
    Srp Arh Celok Lek; 1998; 126(9-10):355-61. PubMed ID: 9863407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective study of carboplatin-based chemotherapy for pediatric germ cell tumors.
    Stern JW; Bunin N
    Med Pediatr Oncol; 2002 Sep; 39(3):163-7. PubMed ID: 12210444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.